| % Gated cells | |||||
|---|---|---|---|---|---|
| Cell cycle phases | Control | Nilotinib (10 μΜ) | Analogue‐1 (10 μΜ) | Analogue‐2 (10 μΜ) | Analogue‐3 (10 μΜ) |
| M1(G0/G1) | 85.14 ± 2.84 | 87.36 ± 2.66* | 79.96 ± 4.53*,** | 81.59 ± 1.19*,** | 78.35 ± 3.51*,** |
| M2(S) | 4.62 ± 1.01 | 3.93 ± 1.05 | 5.38 ± 1.19 | 5.62 ± 0.27 | 6.39 ± 1.03** |
| M3(G2/M) | 9.84 ± 1.92 | 8.18 ± 1.85 | 13.84 ± 3.03*,** | 12.25 ± 0.85*,** | 13.26 ± 2.20*,** |
*P < 0.05 and **P < 0.05 compared with control and Nilotinib, respectively.